The global anti-viral drug therapy market reached a value of nearly $46,456.4 million in 2019, having increased at a compound annual growth rate (CAGR) of 5.0% since 2015. The market is expected to grow from $46,456.4 million in 2019 to $ 61,571.9 million in 2020 at a rate of 32.5%. The growth is mainly due to the increase in number of COVID-19 cases. The market is then expected to grow at a CAGR of 8.3% from 2021 and reach $74,385.9 million in 2023. The market is expected to reach $ 87,230.5 million in 2025, and $ 130,125.3 million in 2030.
Request For The Sample Of The Anti-Viral Drug Therapy Market Here:
The anti-viral drug therapy market consists of sales of branded and generic anti-viral drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-viral drugs to treat microbial infections. The anti-viral drug therapy industry includes establishments that manufacture anti-viral drugs, which are used to treat diseases or illnesses caused by viral infections. Examples of antiviral drugs include idoxuridine, famiciclovir, cidofovir, amantadine, zanamivir, tenofovir, adefovir and ribavirin.
Place A Direct Purchase Order Of The Anti-Viral Drug Therapy Report Here:
The anti-viral drug therapy market report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Some of the major players of the anti-viral drug therapy market are Gilead Sciences Inc, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc.
The anti-viral drug therapy market is segmented by drug class and application.
By Drug Class The anti-viral drug therapy market can be segmented by drug class into
- a. DNA (Nucleotide) Polymerase Inhibitors
- b. Reverse Transcriptase Inhibitors
- c. Protease Inhibitors
- d. Neuraminidase Inhibitors
- e. Others
By Application The anti-viral drug therapy market can be segmented by application into
- a. HIV
- b. Hepatitis
- c. Herpes
- d. Influenza
- e. Others
Read More On The Global Anti-Viral Drug Therapy Market Report:
The anti-viral drug therapy market report describes and explains the global anti-viral drug therapy market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The anti-viral drug therapy report evaluates the market across each region and for the major economies within each region.
The countries covered in the global anti-viral drug therapy market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global anti-viral drug therapy market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Full Report Includes
- Executive Summary
- Report Structure
- Anti-Viral Drug Therapy Market Characteristics
- Anti-Viral Drug Therapy Market Product Analysis
- Anti-Viral Drug Therapy Market Supply Chain
- Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market
- Market Background: Machinery Manufacturing Market
- Copyright And Disclaimer
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model